Brief: Breckenridge Launches Tofacitinib Tablets, Generic Equivalent Of Xeljanz By Pfizer
04/06/2026 16:10
BRIEF-Breckenridge Launches Tofacitinib Tablets, Generic Equivalent Of Xeljanz By Pfizer June 4 (Reuters) - Breckenridge Pharmaceutical:
BRECKENRIDGE ANNOUNCES LAUNCH OF TOFACITINIB TABLETS, GENERIC EQUIVALENT OF XELJANZ® BY PFIZER
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pfizer
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials